These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

71 related items for PubMed ID: 15208163

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Plasma advanced glycation end products are decreased in obese children compared with lean controls.
    Sebeková K, Somoza V, Jarcusková M, Heidland A, Podracká L.
    Int J Pediatr Obes; 2009; 4(2):112-8. PubMed ID: 18645732
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The association of advanced glycation end-products with glutathione status.
    Sahin E, Göçmen AY, Koçak H, Tuncer M, Gümüslü S.
    Ann Clin Biochem; 2008 Jul; 45(Pt 4):369-74. PubMed ID: 18583621
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Alcohol misuse increases serum antibodies to oxidized LDL and C-reactive protein.
    Alho H, Sillanaukee P, Kalela A, Jaakkola O, Laine S, Nikkari ST.
    Alcohol Alcohol; 2004 Jul; 39(4):312-5. PubMed ID: 15208162
    [Abstract] [Full Text] [Related]

  • 8. Short-term low calorie diet intervention reduces serum advanced glycation end products in healthy overweight or obese adults.
    Gugliucci A, Kotani K, Taing J, Matsuoka Y, Sano Y, Yoshimura M, Egawa K, Horikawa C, Kitagawa Y, Kiso Y, Kimura S, Sakane N.
    Ann Nutr Metab; 2009 Jul; 54(3):197-201. PubMed ID: 19420913
    [Abstract] [Full Text] [Related]

  • 9. Associations of serum levels of advanced glycation end products with nutrition markers and anemia in patients with chronic kidney disease.
    Kratochvilová M, Zakiyanov O, Kalousová M, Kříha V, Zima T, Tesař V.
    Ren Fail; 2011 Jul; 33(2):131-7. PubMed ID: 21332333
    [Abstract] [Full Text] [Related]

  • 10. The advanced glycation end product N(epsilon)-carboxymethyllysine is not a predictor of cardiovascular events and renal outcomes in patients with type 2 diabetic kidney disease and hypertension.
    Busch M, Franke S, Wolf G, Brandstädt A, Ott U, Gerth J, Hunsicker LG, Stein G, Collaborative Study Group.
    Am J Kidney Dis; 2006 Oct; 48(4):571-9. PubMed ID: 16997053
    [Abstract] [Full Text] [Related]

  • 11. Effect of high-dose thiamine and pyridoxine on advanced glycation end products and other oxidative stress markers in hemodialysis patients: a randomized placebo-controlled study.
    Nascimento MM, Suliman ME, Murayama Y, Nihi M, Hayashi SY, Stenvinkel P, Riella MC, Lindholm B.
    J Ren Nutr; 2006 Apr; 16(2):119-24. PubMed ID: 16567267
    [Abstract] [Full Text] [Related]

  • 12. Does renal function influence plasma levels of advanced glycation and oxidation protein products in patients with chronic rheumatic diseases complicated by secondary amyloidosis?
    Rysavá R, Kalousová M, Zima T, Dostál C, Merta M, Tesar V.
    Kidney Blood Press Res; 2007 Apr; 30(1):1-7. PubMed ID: 17191033
    [Abstract] [Full Text] [Related]

  • 13. Genomic damage and circulating AGE levels in patients undergoing daily versus standard haemodialysis.
    Fragedaki E, Nebel M, Schupp N, Sebekova K, Völkel W, Klassen A, Pischetsrieder M, Frischmann M, Niwa T, Vienken J, Heidland A, Stopper H.
    Nephrol Dial Transplant; 2005 Sep; 20(9):1936-43. PubMed ID: 15919695
    [Abstract] [Full Text] [Related]

  • 14. Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure.
    Witko-Sarsat V, Friedlander M, Nguyen Khoa T, Capeillère-Blandin C, Nguyen AT, Canteloup S, Dayer JM, Jungers P, Drüeke T, Descamps-Latscha B.
    J Immunol; 1998 Sep 01; 161(5):2524-32. PubMed ID: 9725252
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients.
    Meerwaldt R, Hartog JW, Graaff R, Huisman RJ, Links TP, den Hollander NC, Thorpe SR, Baynes JW, Navis G, Gans RO, Smit AJ.
    J Am Soc Nephrol; 2005 Dec 01; 16(12):3687-93. PubMed ID: 16280473
    [Abstract] [Full Text] [Related]

  • 17. Ceruloplasmin and acute phase protein levels are associated with cardiovascular disease in chronic dialysis patients.
    Panichi V, Taccola D, Rizza GM, Consani C, Migliori M, Filippi C, Paoletti S, Sidoti A, Borracelli D, Panicucci E, Giovannini L.
    J Nephrol; 2004 Dec 01; 17(5):715-20. PubMed ID: 15593040
    [Abstract] [Full Text] [Related]

  • 18. Relationship between proinsulin-to-insulin ratio and advanced glycation endproducts in Japanese type 2 diabetic subjects.
    Saisho Y, Maruyama T, Hirose H, Saruta T.
    Diabetes Res Clin Pract; 2007 Nov 01; 78(2):182-8. PubMed ID: 17467843
    [Abstract] [Full Text] [Related]

  • 19. Low molecular weight advanced glycation end products predict mortality in asymptomatic patients receiving chronic haemodialysis.
    Roberts MA, Thomas MC, Fernando D, Macmillan N, Power DA, Ierino FL.
    Nephrol Dial Transplant; 2006 Jun 01; 21(6):1611-7. PubMed ID: 16520354
    [Abstract] [Full Text] [Related]

  • 20. A novel advanced glycation index and its association with diabetes and microangiopathy.
    Sampathkumar R, Balasubramanyam M, Rema M, Premanand C, Mohan V.
    Metabolism; 2005 Aug 01; 54(8):1002-7. PubMed ID: 16092048
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.